Diseases,
Год журнала:
2023,
Номер
11(4), С. 159 - 159
Опубликована: Ноя. 3, 2023
Post-traumatic
stress
disorder
(PTSD)
is
a
debilitating
mental
health
that
causes
significant
dysfunction
in
individuals.
Currently,
there
are
many
approved
pharmacotherapy
and
psychotherapy
treatment
options
for
PTSD,
but
unfortunately,
half
of
the
patients
do
not
respond
to
traditional
therapies.
In
this
article,
we
review
clinical
trials
research
on
3,4-methylenedioxymethamphetamine
(MDMA)-assisted
PTSD
patients,
its
pharmacokinetics,
current
guidelines
PTSD.
Our
findings
based
results
efficacy
MDMA-assisted
from
six
phase
II
randomized
controlled
trials.
has
received
"breakthrough
therapy"
designation
FDA.
MDMA
can
reduce
symptoms
even
treatment-resistant
cases
by
increasing
certain
neurohormones,
i.e.,
dopamine,
serotonin,
norepinephrine,
oxytocin.
It
also
modulates
activities
brain
regions
involved
fear
anxiety.
Future
needed
show
whether
advantages
outweigh
disadvantages
use
be
integrated
into
available
Current Neuropharmacology,
Год журнала:
2024,
Номер
22(4), С. 636 - 735
Опубликована: Янв. 5, 2024
Post-traumatic
stress
disorder
(PTSD)
is
a
mental
health
condition
that
can
occur
following
exposure
to
traumatic
experience.
An
estimated
12
million
U.S.
adults
are
presently
affected
by
this
disorder.
Current
treatments
include
psychological
therapies
(e.g.,
exposure-based
interventions)
and
pharmacological
selective
serotonin
reuptake
inhibitors
(SSRIs)).
However,
significant
proportion
of
patients
receiving
standard-of-care
for
PTSD
remain
symptomatic,
new
approaches
other
trauma-related
conditions
greatly
needed.
Psychedelic
compounds
alter
cognition,
perception,
mood
currently
being
examined
their
efficacy
in
treating
despite
current
status
as
Drug
Enforcement
Administration
(DEA)-
scheduled
substances.
Initial
clinical
trials
have
demonstrated
the
potential
value
psychedelicassisted
therapy
treat
psychiatric
disorders.
In
comprehensive
review,
we
summarize
state
science
care,
including
shortcomings.
We
review
studies
psychedelic
interventions
PTSD,
disorders,
common
comorbidities.
The
classic
psychedelics
psilocybin,
lysergic
acid
diethylamide
(LSD),
N,N-dimethyltryptamine
(DMT)
DMT-containing
ayahuasca,
well
entactogen
3,4-methylenedioxymethamphetamine
(MDMA)
dissociative
anesthetic
ketamine,
reviewed.
For
each
drug,
present
history
use,
somatic
effects,
pharmacology,
safety
profile.
rationale
proposed
mechanisms
use
traumarelated
disorders
discussed.
This
concludes
with
an
in-depth
consideration
future
directions
applications
maximize
therapeutic
benefit
minimize
risk
individuals
communities
impacted
conditions.
Posttraumatic
Stress
Disorder
(PTSD)
could
potentially
increase
the
risk
of
mortality,
and
there
is
a
need
for
meta-analysis
to
quantify
this
association.
This
study
aims
determine
extent
which
PTSD
predictor
mortality.
Complex Psychiatry,
Год журнала:
2022,
Номер
9(1-4), С. 24 - 43
Опубликована: Сен. 15, 2022
Chronic
pain
is
a
common
condition
with
high
socioeconomic
and
public
health
burden.
A
wide
range
of
psychiatric
conditions
are
often
comorbid
chronic
conditions,
negatively
impacting
successful
treatment
either
condition.
The
receiving
most
attention
in
the
past
regard
to
comorbidity
has
been
major
depressive
disorder,
despite
fact
that
many
other
also
demonstrate
epidemiological
genetic
overlap
pain.
Further
understanding
potential
mechanisms
involved
could
lead
new
strategies
both
for
each
type
disorder
isolation
scenarios
comorbidity.
International Journal of Molecular Sciences,
Год журнала:
2021,
Номер
22(10), С. 5157 - 5157
Опубликована: Май 13, 2021
Post-traumatic
stress
disorder
(PTSD)
is
a
neuropsychiatric
occurring
in
susceptible
individuals
following
traumatic
event.
Understanding
the
mechanisms
subserving
trauma
susceptibility/resilience
essential
to
develop
new
effective
treatments.
Increasing
evidence
suggests
that
non-coding
RNAs,
such
as
microRNAs
(miRNAs),
may
play
prominent
role
mediating
susceptibility/resilience.
In
this
study,
we
evaluated
transcriptional
expression
of
two
key
PTSD-related
genes
(FKBP5
and
BDNF)
relative
targeting
miRNAs
(miR-15a-5p,
miR-497a-5p,
miR-511-5p,
let-7d-5p)
brain
areas
resilient
mice
identified
through
our
recently
developed
mouse
model
PTSD
(arousal-based
individual
screening
(AIS)
model).
We
observed
lower
transcript
levels
miR-15a-5p,
miR-511a-5p
hippocampus
hypothalamus
compared
mice,
suggesting
these
could
discriminate
different
phenotypes
stress-exposed
mice.
These
miRNA
variations
contribute,
individually
or
synergically,
inversely
correlated
FKBP5
BDNF.
Conversely,
medial
prefrontal
cortex,
downregulation
let-7d-5p
was
both
not
accompanied
by
changes
their
mRNA
targets.
Furthermore,
stress-induced
behavioral
scores
(arousal
score,
avoidance-like
social
memory
score
PTSD-like
score),
linear
connection
between
miRNA-based
epigenetic
modulation
phenotypes.
Pathway
analysis
network
showed
statistically
significant
enrichment
molecular
processes
related
stress.
conclusion,
results
indicate
might
be
shaped
brain-area-dependent
FKBP5,
BDNF,
other
stress-related
genes.
Eastern Ukrainian Medical Journal,
Год журнала:
2025,
Номер
13(1), С. 39 - 54
Опубликована: Янв. 1, 2025
Post-traumatic
stress
disorder
(PTSD)
occurs
as
a
result
of
exposure
to
life-threatening
traumatic
event
or
situation
involving
violence.
The
main
manifestations
PTSD
are
obsessive
re-experiencing
the
event,
increased
nervous
arousal,
avoidance
stimuli
related
emotional
and
cognitive
disorders
that
persist
for
long
time.
This
mental
is
exhausting
causes
changes
make
it
difficult
sometimes
impossible
patients
with
function
professionally
socially.
results
in
significant
clinical
burden
high
socioeconomic
costs.
Materials
methods.
authors
have
reviewed
more
than
100
scientific
papers
from
world
literature
on
problems
diagnosis,
symptoms,
pathophysiological
neurobiological
mechanisms
play
an
important
role
development
can
be
used
key
elements
choice
treatment
measures.
Results.
multifactorial
disease,
therefore,
numerous
factors
involved
its
occurrence
progression.
immediate
response
activation
neuroendocrine
autonomic
systems
release
adrenaline
norepinephrine.
involvement
hypothalamic-pituitary-adrenal
system
subsequent
secretion
cortisol
may
trigger
development.
A
link
has
been
found
between
activity
noradrenergic
system,
glucocorticoid
exposure,
impaired
interaction
neurons
amygdala
prefrontal
cortex.
In
addition,
glucocorticoids
associated
immune
neuroinflammation.
Inflammatory
cytokines
regulate
modify
functioning
neurotransmitters
such
serotonin
dopamine,
which
contributes
onset
progression
symptoms.
Conclusions.
data
large
number
studies
allow
us
confirm
following
pathogenesis
PTSD.
These
include
vegetative
regulation,
dysfunction
immunological
regulatory
inflammatory
mechanisms,
dysregulation
monoaminergic
transmission
system.
Further
study
pathogenetic
pathways
will
better
implementation
strategy
medical
care
Journal of Neuroimmune Pharmacology,
Год журнала:
2023,
Номер
18(3), С. 248 - 266
Опубликована: Апрель 25, 2023
Abstract
Post-traumatic
stress
disorder
(PTSD)
is
a
chronic
incapacitating
condition
with
recurrent
experience
of
trauma-related
memories,
negative
mood,
altered
cognition,
and
hypervigilance.
Agglomeration
preclinical
clinical
evidence
in
recent
years
specified
that
alterations
neural
networks
favor
certain
characteristics
PTSD.
Besides
the
disruption
hypothalamus-pituitary-axis
(HPA)
axis,
intensified
immune
status
elevated
pro-inflammatory
cytokines
arachidonic
metabolites
COX-2
such
as
PGE2
creates
putative
scenario
worsening
neurobehavioral
facet
This
review
aims
to
link
Diagnostic
Statistical
Manual
mental
disorders
(DSM-V)
symptomology
major
mechanisms
are
supposed
underpin
transition
from
acute
reactions
development
Also,
demonstrate
how
these
intertwined
processes
can
be
applied
probable
early
intervention
strategies
followed
by
description
supporting
proposed
mechanisms.
Hence
this
review,
several
network
were
postulated
concerning
HPA
COX-2,
PGE2,
NLRP3,
sirtuins
unravel
possible
complex
neuroinflammatory
obscured
PTSD
condition.
Translational Psychiatry,
Год журнала:
2023,
Номер
13(1)
Опубликована: Дек. 7, 2023
Abstract
Current
evidence-based
treatments
for
post-traumatic
stress
disorder
(PTSD)
are
efficacious
in
only
part
of
PTSD
patients.
Therefore,
novel
neurobiologically
informed
approaches
urgently
needed.
Clinical
and
translational
neuroscience
point
to
altered
learning
memory
processes
as
key
(models
of)
psychopathology.
We
extended
this
notion
by
clarifying
at
a
meta-level
(i)
the
role
information
valence,
i.e.
neutral
versus
emotional/fearful,
(ii)
comparability,
far
applicable,
between
clinical
preclinical
phenotypes.
hypothesized
that
cross-species,
emotional/fearful
processing
is,
respectively,
impaired
enhanced
PTSD.
This
preregistered
meta-analysis
involved
literature
search
on
PTSD+Learning/Memory+Behavior,
performed
PubMed.
First,
effect
valence
was
estimated
with
random-effects
meta-regression.
The
sources
variation
were
explored
random
forest-based
analysis.
analyses
included
92
(
N
=
6732
humans)
182
6834
animals)
studies.
A
general
impairment
learning,
extinction
observed
patients,
regardless
valence.
Impaired
learning/memory
fear
also
present
animal
models
Yet,
fear/trauma
studies
emotional
data
limited.
Mnemonic
phase
explained
most
rodents
but
not
humans.
show
stable
cross-species
These
could
be
targeted
treatments,
using
gained
from
neurobiological
argue
apparent
discrepancies
deserve
further
in-depth
study;
until
then,
targeting
phenotype
should
applied
utmost
care.
Jentashapir Journal of Cellular and Molecular Biology,
Год журнала:
2025,
Номер
16(1)
Опубликована: Янв. 12, 2025
Background:
Extensive
evidence
demonstrates
that
neuronal
autophagic
and
cytoskeletal
elements
play
critical
roles
in
neuroplasticity.
Dysregulation
of
neuroplasticity
has
been
implicated
the
pathology
depression
post-traumatic
stress
disorder
(PTSD).
Transcription
factor
EB
(TFEB)
stathmin
are
key
regulators
autophagy
microtubule
formation,
respectively.
Objectives:
The
current
study
aimed
to
compare
levels
hippocampal
TFEB
proteins
PTSD
depressed
animal
models
rats.
Methods:
Three
groups
male
rat
pups
(n
=
8)
were
used.
first
group,
designated
as
was
exposed
maternal
separation
related
stressors.
second
representing
model,
single-prolonged
stress.
third
group
served
control.
Anxiety-like
depressive-like
behaviors
evaluated
using
elevated
plus
maze
(EPM)
forced
swimming
test
(FST).
Hippocampal
protein
measured
western
blotting.
Data
analyzed
Prism
software.
One-way
ANOVA
post
hoc
Tukey
tests
performed
evaluate
statistical
differences
between
behavioral
tasks.
Independent
t-tests
used
assess
groups.
Results:
increased
both
rats,
while
decreased.
effect
on
expression
significantly
higher
than
PTSD.
Conversely,
reduction
more
pronounced
compared
Conclusions:
These
results
suggest
changes
may
be
associated
with
anxiety-
depression-like
behaviors.